中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
MeSH:(Olanzapine/metabolism*)

1.Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.

Rong LI ; Wenqiang ZHU ; Piaopiao HUANG ; Chen DING ; Yaxin TANG ; Ping'an LIAN ; Xiansheng HUANG

Journal of Central South University(Medical Sciences) 2022;47(6):730-738

2.Effects of ziprasidone and olanzapine on glucose and lipid metabolism in first-episode schizophrenia.

Ping SHAO ; Jianjun OU ; Renrong WU ; Maosheng FANG ; Honghui CHEN ; Yi XU ; Jingping ZHAO

Journal of Central South University(Medical Sciences) 2013;38(4):365-369

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO